Nanomechanical effects of aldosterone on vaso-occulation in sickle cell disease

醛固酮对镰状细胞病血管阻塞的纳米力学影响

基本信息

  • 批准号:
    8014934
  • 负责人:
  • 金额:
    $ 13.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-08 至 2010-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cardiovascular research in the last decade has definitively shown that the hormone aldosterone has pro- inflammatory vascular effects, including biophysical changes in endothelial cells such as: increased cell stiffness, increased cell volume, increased surface adhesion molecule expression, and decreased nitric oxide production, among others. What has not been studied, however, is how these aldosterone-induced alterations in endothelial cell mechanical properties affect sickle cell vaso-occlusion, which is also a biophysical phenomenon, and how aldosterone may also alter the biophysical properties of blood cells. We hypothesize that aldosterone-mediated cell mechanical effects influence sickle cell vaso-occlusion and propose to use single-cell mechanical techniques that we have previously developed in combination with conventional assays to explore how aldosterone affects microvascular occlusion. Specifically, we will determine and investigate the underlying mechanisms of aldosterone's effect on endothelial adhesion to sickle red cells and leukocytes (Aim 1), sickle red cell and leukocyte deformability (Aim 2), and cell aggregation and microcirculatory flow in a three-dimensional in vitro model of the microvasculature (Aim 3). The candidate has chosen a novel training and career path and has recently completed a fellowship in pediatric hematology/oncology combined with a PhD in bioengineering. This K08 grant will allow Dr. Lam to receive all the necessary training to develop into a new breed of independent researcher in academic medicine: a physician-scientist-engineer who applies bioengineering and nanoscience techniques to develop new biomedical devices for diagnosis and study of pediatric blood diseases. Specifically, this award will be used to further his training in vascular biology, the cell biology of adhesion, and advanced microfabrication and microfluidics to develop complex lab-on-chip devices for sickle cell disease. This research will be conducted in a unique bioengineering lab at UC Berkeley that focuses on applying and developing new optical microscopy, force microscopy, and microfluidic techniques to study cell mechanics in health and disease, with close clinical connections at UC San Francisco. RELEVANCE (See instructions): By investigating whether the hormone aldosterone plays a role in sickle cell anemia, this work will improve our understanding of- and new treatments for-this complex and incurable disease. In addition, the devices we develop for this project will serve as prototypes for new diagnostic and drug discovery tools for this debilitating and potentially fatal disease that affects the lives of tens of thousands of Americans every day.
描述(由申请人提供):在过去十年中的心血管研究已经明确显示激素醛固酮具有促炎性血管作用,包括内皮细胞中的生物物理变化,例如:增加的细胞硬度、增加的细胞体积、增加的表面粘附分子表达和减少的一氧化氮产生等.然而,尚未研究的是这些醛固酮诱导的内皮细胞机械性质的改变如何影响镰状细胞血管闭塞,这也是一种生物物理现象,以及醛固酮如何也可能改变血细胞的生物物理性质。我们假设醛固酮介导的细胞机械效应影响镰状细胞血管闭塞,并建议使用单细胞机械技术,我们以前开发的结合传统的检测方法,探讨醛固酮如何影响微血管闭塞。具体而言,我们将确定和研究醛固酮对内皮细胞粘附镰状红细胞和白细胞(目标1),镰状红细胞和白细胞变形性(目标2),细胞聚集和微循环流动的三维体外模型的微血管系统(目标3)的影响的潜在机制。候选人选择了一条新的培训和职业道路,最近完成了儿科血液学/肿瘤学奖学金,并获得了生物工程博士学位。这K 08赠款将允许林博士接受所有必要的培训,发展成为一个新的品种的独立研究人员在学术医学:一个医生,科学家,工程师谁应用生物工程和纳米科学技术,开发新的生物医学设备的诊断和儿科血液疾病的研究。具体而言,该奖项将用于进一步培训他在血管生物学,细胞生物学的粘附,先进的微加工和微流体开发复杂的芯片实验室设备的镰状细胞病。这项研究将在加州大学伯克利分校一个独特的生物工程实验室进行,该实验室专注于应用和开发新的光学显微镜,力显微镜和微流体技术,以研究健康和疾病中的细胞力学,并与加州大学旧金山分校弗朗西斯科密切临床联系。相关性(参见说明):通过研究醛固酮激素是否在镰状细胞性贫血中起作用,这项工作将提高我们对这种复杂且无法治愈的疾病的理解和新的治疗方法。此外,我们为这个项目开发的设备将作为新的诊断和药物发现工具的原型,用于这种每天影响成千上万美国人生活的使人衰弱和潜在致命的疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wilbur A Lam其他文献

Effect of Epitope Specific Antibodies on Single Platelet Physiology with Implications for Immune Thrombocytopenia Purpura
  • DOI:
    10.1182/blood-2022-159547
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Nina Shaver;Oluwamayokun Oshinowo;Meredith E. Fay;David R. Myers;Wilbur A Lam
  • 通讯作者:
    Wilbur A Lam

Wilbur A Lam的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wilbur A Lam', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10265612
  • 财政年份:
    2020
  • 资助金额:
    $ 13.2万
  • 项目类别:
Engineering biophysical microtechnologies for hematologic applications in health and disease
工程生物物理微技术在健康和疾病中的血液学应用
  • 批准号:
    10579951
  • 财政年份:
    2019
  • 资助金额:
    $ 13.2万
  • 项目类别:
Engineering biophysical microtechnologies for hematologic applications in health and disease
工程生物物理微技术在健康和疾病中的血液学应用
  • 批准号:
    10350610
  • 财政年份:
    2019
  • 资助金额:
    $ 13.2万
  • 项目类别:
Engineering biophysical microtechnologies for hematologic applications in health and disease
工程生物物理微技术在健康和疾病中的血液学应用
  • 批准号:
    9898450
  • 财政年份:
    2019
  • 资助金额:
    $ 13.2万
  • 项目类别:
SBIR phase II: A personalized, non-invasive hemoglobin level monitoring and management platform for chronic anemia patients.
SBIR II 期:针对慢性贫血患者的个性化、无创血红蛋白水平监测和管理平台。
  • 批准号:
    10458078
  • 财政年份:
    2018
  • 资助金额:
    $ 13.2万
  • 项目类别:
Emergency COVID-19 Variant Supplement for Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)
亚特兰大微系统工程护理点技术中心 (ACME POCT) 的紧急 COVID-19 变异补充品
  • 批准号:
    10476947
  • 财政年份:
    2018
  • 资助金额:
    $ 13.2万
  • 项目类别:
SBIR phase II: A personalized, non-invasive hemoglobin level monitoring and management platform for chronic anemia patients.
SBIR II 期:针对慢性贫血患者的个性化、无创血红蛋白水平监测和管理平台。
  • 批准号:
    10325763
  • 财政年份:
    2018
  • 资助金额:
    $ 13.2万
  • 项目类别:
Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)
亚特兰大微系统工程护理点技术中心 (ACME POCT)
  • 批准号:
    10715493
  • 财政年份:
    2018
  • 资助金额:
    $ 13.2万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10715494
  • 财政年份:
    2018
  • 资助金额:
    $ 13.2万
  • 项目类别:
Redefining Clinical Viscosity in Sickle Cell Diseaseby Leveraging Microfluidic Technologies
利用微流体技术重新定义镰状细胞病的临床粘度
  • 批准号:
    10022309
  • 财政年份:
    2018
  • 资助金额:
    $ 13.2万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.2万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.2万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.2万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 13.2万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 13.2万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 13.2万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 13.2万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 13.2万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 13.2万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 13.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了